Foresee Pharmaceuticals Co., Ltd. announced a private placement of 78,410 common shares at a price of $100 per share for the gross proceeds of $7,841,000 on may 3, 2024. The transaction has been approved by the shareholders of the company.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
97.5 TWD | +0.10% |
|
+0.52% | +1.35% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.35% | 411M | |
+48.54% | 56.61B | |
+36.61% | 39.25B | |
-6.02% | 39.62B | |
-6.90% | 28.28B | |
+12.97% | 26.44B | |
-16.91% | 20.12B | |
+31.71% | 12.48B | |
+28.18% | 12.51B | |
+0.38% | 12.2B |
- Stock Market
- Equities
- 6576 Stock
- News Foresee Pharmaceuticals Co., Ltd.
- Foresee Pharmaceuticals Co., Ltd. announced that it expects to receive $7.841 million in funding